Bleeding patterns after misoprostol vs surgical treatment of early pregnancy failure: results from a randomized trial

Anne R. Davis, Sarah K. Hendlish, Carolyn Westhoff, Margaret M. Frederick, Jun Zhang, Jerry M. Gilles, Kurt Barnhart, Mitchell D Creinin

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

Objective: The purpose of this study was to describe bleeding patterns after misoprostol or curettage for early pregnancy failure (EPF). Study design: This was a randomized trial that included women (n = 652) with EPF. Participants were assigned to vaginal misoprostol (800 μg) or curettage in a 3:1 ratio. Participants completed a bleeding diary. We measured hemoglobin levels at baseline and 2 weeks after the treatment. Results: Decreases in hemoglobin levels were greater after misoprostol (-0.7 g/dL; SD, 1.2) than curettage (-0.2 g/dL; SD, 0.9; P < .001). Large changes in hemoglobin levels (at least 2 g/dL) or low nadir hemoglobin levels (< 10 g/dL) were more frequent after misoprostol (55/428 women; 12.8%) than after curettage (6/135 women; 4.4%; P = .02). More participants in the misoprostol group reported "any bleeding" or "heavy bleeding" every study day. Four women who were treated with misoprostol required blood transfusion. Conclusion: Bleeding is heavier and more prolonged after medical treatment with misoprostol than with curettage for EPF; however, bleeding rarely requires intervention.

Original languageEnglish (US)
JournalAmerican Journal of Obstetrics and Gynecology
Volume196
Issue number1
DOIs
StatePublished - Jan 2007
Externally publishedYes

Fingerprint

Misoprostol
Curettage
Hemorrhage
Pregnancy
Hemoglobins
Therapeutics
Blood Transfusion

Keywords

  • curettage
  • early pregnancy failure
  • miscarriage
  • misoprostol

ASJC Scopus subject areas

  • Medicine(all)
  • Obstetrics and Gynecology

Cite this

Bleeding patterns after misoprostol vs surgical treatment of early pregnancy failure : results from a randomized trial. / Davis, Anne R.; Hendlish, Sarah K.; Westhoff, Carolyn; Frederick, Margaret M.; Zhang, Jun; Gilles, Jerry M.; Barnhart, Kurt; Creinin, Mitchell D.

In: American Journal of Obstetrics and Gynecology, Vol. 196, No. 1, 01.2007.

Research output: Contribution to journalArticle

Davis, Anne R. ; Hendlish, Sarah K. ; Westhoff, Carolyn ; Frederick, Margaret M. ; Zhang, Jun ; Gilles, Jerry M. ; Barnhart, Kurt ; Creinin, Mitchell D. / Bleeding patterns after misoprostol vs surgical treatment of early pregnancy failure : results from a randomized trial. In: American Journal of Obstetrics and Gynecology. 2007 ; Vol. 196, No. 1.
@article{18ef91174cf8403cbf8a17b2ea81ed95,
title = "Bleeding patterns after misoprostol vs surgical treatment of early pregnancy failure: results from a randomized trial",
abstract = "Objective: The purpose of this study was to describe bleeding patterns after misoprostol or curettage for early pregnancy failure (EPF). Study design: This was a randomized trial that included women (n = 652) with EPF. Participants were assigned to vaginal misoprostol (800 μg) or curettage in a 3:1 ratio. Participants completed a bleeding diary. We measured hemoglobin levels at baseline and 2 weeks after the treatment. Results: Decreases in hemoglobin levels were greater after misoprostol (-0.7 g/dL; SD, 1.2) than curettage (-0.2 g/dL; SD, 0.9; P < .001). Large changes in hemoglobin levels (at least 2 g/dL) or low nadir hemoglobin levels (< 10 g/dL) were more frequent after misoprostol (55/428 women; 12.8{\%}) than after curettage (6/135 women; 4.4{\%}; P = .02). More participants in the misoprostol group reported {"}any bleeding{"} or {"}heavy bleeding{"} every study day. Four women who were treated with misoprostol required blood transfusion. Conclusion: Bleeding is heavier and more prolonged after medical treatment with misoprostol than with curettage for EPF; however, bleeding rarely requires intervention.",
keywords = "curettage, early pregnancy failure, miscarriage, misoprostol",
author = "Davis, {Anne R.} and Hendlish, {Sarah K.} and Carolyn Westhoff and Frederick, {Margaret M.} and Jun Zhang and Gilles, {Jerry M.} and Kurt Barnhart and Creinin, {Mitchell D}",
year = "2007",
month = "1",
doi = "10.1016/j.ajog.2006.07.053",
language = "English (US)",
volume = "196",
journal = "American Journal of Obstetrics and Gynecology",
issn = "0002-9378",
publisher = "Mosby Inc.",
number = "1",

}

TY - JOUR

T1 - Bleeding patterns after misoprostol vs surgical treatment of early pregnancy failure

T2 - results from a randomized trial

AU - Davis, Anne R.

AU - Hendlish, Sarah K.

AU - Westhoff, Carolyn

AU - Frederick, Margaret M.

AU - Zhang, Jun

AU - Gilles, Jerry M.

AU - Barnhart, Kurt

AU - Creinin, Mitchell D

PY - 2007/1

Y1 - 2007/1

N2 - Objective: The purpose of this study was to describe bleeding patterns after misoprostol or curettage for early pregnancy failure (EPF). Study design: This was a randomized trial that included women (n = 652) with EPF. Participants were assigned to vaginal misoprostol (800 μg) or curettage in a 3:1 ratio. Participants completed a bleeding diary. We measured hemoglobin levels at baseline and 2 weeks after the treatment. Results: Decreases in hemoglobin levels were greater after misoprostol (-0.7 g/dL; SD, 1.2) than curettage (-0.2 g/dL; SD, 0.9; P < .001). Large changes in hemoglobin levels (at least 2 g/dL) or low nadir hemoglobin levels (< 10 g/dL) were more frequent after misoprostol (55/428 women; 12.8%) than after curettage (6/135 women; 4.4%; P = .02). More participants in the misoprostol group reported "any bleeding" or "heavy bleeding" every study day. Four women who were treated with misoprostol required blood transfusion. Conclusion: Bleeding is heavier and more prolonged after medical treatment with misoprostol than with curettage for EPF; however, bleeding rarely requires intervention.

AB - Objective: The purpose of this study was to describe bleeding patterns after misoprostol or curettage for early pregnancy failure (EPF). Study design: This was a randomized trial that included women (n = 652) with EPF. Participants were assigned to vaginal misoprostol (800 μg) or curettage in a 3:1 ratio. Participants completed a bleeding diary. We measured hemoglobin levels at baseline and 2 weeks after the treatment. Results: Decreases in hemoglobin levels were greater after misoprostol (-0.7 g/dL; SD, 1.2) than curettage (-0.2 g/dL; SD, 0.9; P < .001). Large changes in hemoglobin levels (at least 2 g/dL) or low nadir hemoglobin levels (< 10 g/dL) were more frequent after misoprostol (55/428 women; 12.8%) than after curettage (6/135 women; 4.4%; P = .02). More participants in the misoprostol group reported "any bleeding" or "heavy bleeding" every study day. Four women who were treated with misoprostol required blood transfusion. Conclusion: Bleeding is heavier and more prolonged after medical treatment with misoprostol than with curettage for EPF; however, bleeding rarely requires intervention.

KW - curettage

KW - early pregnancy failure

KW - miscarriage

KW - misoprostol

UR - http://www.scopus.com/inward/record.url?scp=33846240451&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33846240451&partnerID=8YFLogxK

U2 - 10.1016/j.ajog.2006.07.053

DO - 10.1016/j.ajog.2006.07.053

M3 - Article

C2 - 17240222

AN - SCOPUS:33846240451

VL - 196

JO - American Journal of Obstetrics and Gynecology

JF - American Journal of Obstetrics and Gynecology

SN - 0002-9378

IS - 1

ER -